Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hemodynamically Important PDA in Newborns Under 32 Weeks: Clinical and Echocardiographic Findings and Outcomes

NCT05686343 is registered in ClinicalTrials.gov with Ankara University as lead sponsor.

NCT NCT05686343
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05686343 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hemodynamically Important PDA in Newborns Under 32 Weeks: Clinical and Echocardiographic Findings and Outcomes
Lead sponsor
Ankara University
Phase
Observational
Overall status
Unknown status
Start date
July 1, 2022
Completion date
July 1, 2023
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

patent ductus arteriosus after premature birth